Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV

Jake A. Ruddy; Brian J. Boyarsky; Justin R. Bailey; Andrew H. Karaba; Jacqueline M. Garonzik-Wang; Dorry L. Segev; Christine M. Durand; William A. Werbel

doi:10.1097/QAD.0000000000003017

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV

Jake A. Ruddy, Brian J. Boyarsky, Justin R. Bailey, Andrew H. Karaba, Jacqueline M. Garonzik-Wang, Dorry L. Segev, Christine M. Durand, William A. Werbel

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Abstract

This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV (PWH) demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain (RBD) antibody titres after two doses, despite varied titres after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.

Original language	English (US)
Pages (from-to)	2399-2401
Number of pages	3
Journal	AIDS (London, England)
Volume	35
Issue number	14
DOIs	https://doi.org/10.1097/QAD.0000000000003017
State	Published - Nov 15 2021

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Infectious Diseases

Access to Document

10.1097/QAD.0000000000003017

Cite this

@article{5475e85e285844b0ba6b6c1e35bf0e26,

title = "Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV",

abstract = "This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV (PWH) demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain (RBD) antibody titres after two doses, despite varied titres after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.",

author = "Ruddy, {Jake A.} and Boyarsky, {Brian J.} and Bailey, {Justin R.} and Karaba, {Andrew H.} and Garonzik-Wang, {Jacqueline M.} and Segev, {Dorry L.} and Durand, {Christine M.} and Werbel, {William A.}",

year = "2021",

month = nov,

day = "15",

doi = "10.1097/QAD.0000000000003017",

language = "English (US)",

volume = "35",

pages = "2399--2401",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "14",

}

TY - JOUR

T1 - Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV

AU - Ruddy, Jake A.

AU - Boyarsky, Brian J.

AU - Bailey, Justin R.

AU - Karaba, Andrew H.

AU - Garonzik-Wang, Jacqueline M.

AU - Segev, Dorry L.

AU - Durand, Christine M.

AU - Werbel, William A.

PY - 2021/11/15

Y1 - 2021/11/15

N2 - This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV (PWH) demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain (RBD) antibody titres after two doses, despite varied titres after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.

AB - This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV (PWH) demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain (RBD) antibody titres after two doses, despite varied titres after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.

UR - http://www.scopus.com/inward/record.url?scp=85117907897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85117907897&partnerID=8YFLogxK

U2 - 10.1097/QAD.0000000000003017

DO - 10.1097/QAD.0000000000003017

M3 - Letter

C2 - 34261097

AN - SCOPUS:85117907897

SN - 0269-9370

VL - 35

SP - 2399

EP - 2401

JO - AIDS

JF - AIDS

IS - 14

ER -

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this